Clinical Trials Directory

Trials / Completed

CompletedNCT06555705

Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children

Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children, a Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
5 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Evidence shows that omega-3 fatty acids lower blood triglyceride levels, lower blood pressure, enhance insulin sensitivity, and improve heart rate variability (HRV) measures, all of which may be indicators of cardiovascular health.As a result, omega-3 fatty acid supplementation may be a low-cost strategy with little adverse effects for obese youngsters, perhaps delaying the development of chronic cardiovascular illnesses.

Detailed description

This is a two-armed study , the interventional group will be given omega 3 and the control group will be given a placebo and both will be examined for the heart rate variability

Conditions

Interventions

TypeNameDescription
OTHERPlaceboThe control group will be given placebo for 3 months
DIETARY_SUPPLEMENTOmega 3The interventional group will be given omega 3 for 3 months

Timeline

Start date
2024-04-03
Primary completion
2024-08-25
Completion
2024-09-03
First posted
2024-08-15
Last updated
2025-03-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06555705. Inclusion in this directory is not an endorsement.